Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Identification of risk profiles for liver injury in adults with multiple sclerosis using artificial intelligence method.
Journal: Multiple sclerosis and related disorders
Published: May 05, 2025
Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis.
Journal: Multiple sclerosis and related disorders
Published: September 20, 2022
Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide.
Journal: Frontiers in neurology
Published: December 03, 2021
Teriflunomide Inhibits JCPyV Infection and Spread in Glial Cells and Choroid Plexus Epithelial Cells.
Journal: International journal of molecular sciences
Published: July 16, 2021
Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.
Journal: BMC neurology
Published: April 08, 2020
Long-term safety and efficacy of teriflunomide in patients with relapsing multiple sclerosis: Results from the TOWER extension study.
Journal: Multiple sclerosis and related disorders
Published: February 26, 2020
Comparative effectiveness of teriflunomide and dimethyl fumarate in patients with relapsing forms of MS in the retrospective real-world Teri-RADAR study.
Journal: Journal of comparative effectiveness research
Published: February 14, 2019
Showing 1-7 of 7
Last Updated: 09/26/2026